Barclays’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $799K | Buy |
71,672
+40,508
| +130% | +$452K | ﹤0.01% | 2800 |
|
|
2025
Q1 | $383K | Buy |
31,164
+3,555
| +13% | +$43.7K | ﹤0.01% | 2992 |
|
|
2024
Q4 | $309K | Buy |
27,609
+6,976
| +34% | +$78.1K | ﹤0.01% | 3315 |
|
|
2024
Q3 | $144K | Buy |
20,633
+16,007
| +346% | +$112K | ﹤0.01% | 3638 |
|
|
2024
Q2 | $35K | Sell |
4,626
-9,244
| -67% | -$69.9K | ﹤0.01% | 3789 |
|
|
2024
Q1 | $183K | Sell |
13,870
-101
| -0.7% | -$1.33K | ﹤0.01% | 3382 |
|
|
2023
Q4 | $144K | Buy |
13,971
+3,132
| +29% | +$32.3K | ﹤0.01% | 3619 |
|
|
2023
Q3 | $105K | Buy |
10,839
+10,721
| +9,086% | +$104K | ﹤0.01% | 3316 |
|
|
2023
Q2 | $1K | Hold |
118
| – | – | ﹤0.01% | 4192 |
|
|
2023
Q1 | $1K | Hold |
118
| – | – | ﹤0.01% | 4256 |
|
|
2022
Q4 | $0 | Sell |
118
-3,100
| -96% | – | ﹤0.01% | 4471 |
|
|
2022
Q3 | $12K | Sell |
3,218
-183
| -5% | -$682 | ﹤0.01% | 4110 |
|
|
2022
Q2 | $17K | Sell |
3,401
-1,152
| -25% | -$5.76K | ﹤0.01% | 4154 |
|
|
2022
Q1 | $38K | Buy |
+4,553
| New | +$38K | ﹤0.01% | 4111 |
|